The Member States are invited to establish overall strategies incorporating aspects such as access to care (diagnostics, treatments and orphan drugs), the provision of information to patients and research.
Liikmesriikidel palutakse kehtestada üldstrateegiad, mis hõlmaksid selliseid aspekte nagu juurdepääs ravile (diagnostika, ravimine ja harva kasutatavad ravimid), patsientide teavitamine ja teadusuuringud.